<DOC>
	<DOCNO>NCT00745498</DOCNO>
	<brief_summary>The purpose study determine effect pre- intra-operative bevacizumab injection postoperative vitreous hemorrhage diabetic vitrectomy .</brief_summary>
	<brief_title>Pre- Intra-operative Intravitreal Bevacizumab Injection Diabetic Vitrectomy</brief_title>
	<detailed_description>Postoperative vitreous hemorrhage ( VH ) common complication vitrectomy proliferative diabetic retinopathy . Persistent recurrent VH delay visual rehabilitation give patient much trouble . There effort low incidence postoperative VH use intraoperative gas tamponade preoperative bevacizumab injection . Bevacizumab ( Avastin ) potent inhibitor angiogenesis show decrease retinal iris neovascularization proliferative diabetic retinopathy . Recently report show preoperative intravitreal bevacizumab ( IVB ) injection could reduce intraoperative bleeding abnormal vessel could make surgery easy successful.Our hypothesis preoperative bevacizumab injection could reduce postoperative VH way decrease amount abnormal vessel intraoperative injection could also reduce postoperative VH inhibit vessel formation surgery . To prove hypothesis , start prospective randomize comparative study determine effect pre- intra-operative IVB injection postoperative vitreous hemorrhage diabetic vitrectomy .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Vitreous Hemorrhage</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Patients undergo first vitrectomy complication proliferative diabetic retinopathy vitreous hemorrhage , tractional fibrovascular membrane proliferation , tractional combine retinal detachment ) Followup period le 6 month Intraoperative use longacting gas silicone oil Repeat vitrectomy first vitrectomy disease vitreous hemorrhage Not first vitrectomy Uncontrolled hypertension Medical history abnormal blood coagulation Time interval IVB injection PPV longer 2 week recent history ( within 3 month ) IVB treatment</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Proliferative diabetic retinopathy</keyword>
	<keyword>vitrectomy</keyword>
	<keyword>bevacizumab</keyword>
	<keyword>vitreous hemorrhage</keyword>
</DOC>